Work

Indoleamine 2,3-dioxygenase provides adaptive resistance to immune checkpoint inhibitors in hepatocellular carcinoma

Year: 2018

Type: article

Source: Cancer Immunology Immunotherapy

DOI: 10.1007/s00262-018-2190-4

Authors: Zachary J. Brown, Su Jong Yu, Bernd Heinrich, Chi Ma, Qiong Fu, Milan Sandhu, David Agdashian, Qianfei Zhang, Firouzeh Korangy, Tim F. Greten

Institutions: National Institutes of Health, National Cancer Institute, Center for Cancer Research, Seoul National University

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Cancer Institute

Awards: G6374948078, G7472767939

OpenAlex ID: W2809833956

FWCI: 5.159

Cites: 45

Cited by: 116

Related to: 10